Dow Down 0.02% Nasdaq Up 0.07%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
14.46 Nov 25, 4:00PM EST
Prev Close:14.46
Open:N/A
Bid:14.07 x 800
Ask:14.69 x 400
1y Target Est:17.71
Beta:0.07
Earnings Date:Dec 8 - Dec 12 (Est.)
Day's Range:N/A - N/A
52wk Range:2.62 - 14.52
Volume:0
Avg Vol (3m):6,110,140
Market Cap:2.48B
P/E (ttm):N/A
EPS (ttm):-0.46
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AVNR 0.00%2.48B
BMY97.07B
LLY71.50B
GSK111.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-2.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback